Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Livzon Pharmaceutical Group Inc.
  6. News
  7. Summary
    000513   CNE0000002Y8

LIVZON PHARMACEUTICAL GROUP INC.

(000513)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Livzon Pharma Completes Purchase of 40% Stake in IPO Hopeful Tianjin Tongrentang for $111 Million

04/28/2021 | 06:34am EDT


© MT Newswires 2021
All news about LIVZON PHARMACEUTICAL GROUP INC.
06/15LIVZON PHARMACEUTICAL  : Pharma's GERD Medication Passes Generic Drug Evaluation..
MT
05/12LIVZON PHARMACEUTICAL  : Announcement on progress of the reorganization
PU
05/06LIVZON PHARMACEUTICAL  : Cancellation of the repurchased h shares
PU
05/06LIVZON PHARMACEUTICAL  : Voluntary announcement launch of futures hedging activi..
PU
05/06LIVZON PHARMACEUTICAL  : Poll results of the 2021 second extraordinary general m..
PU
04/28Livzon Pharma Completes Purchase of 40% Stake in IPO Hopeful Tianjin Tongrent..
MT
04/27LIVZON PHARMACEUTICAL  : Voluntary announcement update announcement on acquisiti..
PU
04/23LIVZON PHARMACEUTICAL  : Circular of the annual general meeting for the year 202..
PU
04/22Hong Kong Stocks Rebound from 2% Rout; Livzon Pharma Gains 4%
MT
04/22Chinese Shares End Mixed; Great Wall Motor Slides 4%, Livzon Jumps 6% After Q..
MT
More news
Financials
Sales 2021 11 950 M 1 852 M 1 852 M
Net income 2021 1 941 M 301 M 301 M
Net cash 2021 6 381 M 989 M 989 M
P/E ratio 2021 22,5x
Yield 2021 2,70%
Capitalization 39 117 M 6 062 M 6 062 M
EV / Sales 2021 2,74x
EV / Sales 2022 2,39x
Nbr of Employees 8 367
Free-Float 36,6%
Chart LIVZON PHARMACEUTICAL GROUP INC.
Duration : Period :
Livzon Pharmaceutical Group Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIVZON PHARMACEUTICAL GROUP INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 48,70 CNY
Last Close Price 47,60 CNY
Spread / Highest target 32,1%
Spread / Average Target 2,31%
Spread / Lowest Target -33,8%
EPS Revisions
Managers and Directors
NameTitle
Yang Gang Tang President & Executive Director
Yan Xia Si Chief Financial Officer & Vice President
Bao Guo Zhu Chairman
Maolin Wang Chairman-Supervisory Board
Xiao Jun Wang Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
LIVZON PHARMACEUTICAL GROUP INC.17.53%6 093
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939